Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Notice of Proposed Sale · 144

Quest Diagnostics Inc.

DGXNYSEEQUITYCurrent

Notice of Proposed Sale

Filed Sep 1, 2026Accepted Sep 1, 2026, 11:06 AM EDTFiling CIK 1022079Accession 0001959173-26-006569
Share

Structured filing — 144

primary_doc.xml

Open full document ↗

Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.

Proposed-sale notice

Issuer
QUEST DIAGNOSTICS INC
Issuer CIK
0001022079
SEC file number
001-12215
Phone
9735202700
Person for whose account securities are to be sold
Davis J. E.
Relationships to issuer
Officer · Director
Street
500 PLAZA DRIVE
City
SECAUCUS
State / country code
NJ
Postal code
07094

Securities proposed for sale

Securities proposed for sale · 1 reported row
SecurityProposed unitsAggregate market valueUnits outstandingApproximate sale dateExchangeBroker / market maker
Common10,0002,427,200.00110,373,36009/01/2026NYSEFidelity Brokerage Services LLC

Broker / market maker — proposed row 1, entry 1

Name
Fidelity Brokerage Services LLC
Street
900 Salem Street
City
Smithfield
State / country code
RI
Postal code
02917

Acquisition of securities to be sold

Acquisition of securities to be sold · 4 reported rows
SecurityAcquiredNature of acquisitionAcquired fromAmount acquiredGift transactionPayment dateNature of payment
Common02/18/2022Restricted Stock VestingIssuer5,115N02/18/2022Compensation
Common02/17/2024Restricted Stock VestingIssuer829N02/17/2024Compensation
Common02/23/2024Restricted Stock VestingIssuer2,598N02/23/2024Compensation
Common02/24/2024Restricted Stock VestingIssuer1,458N02/24/2024Compensation

Sales reported in the preceding three months

Sales reported in the preceding three months · 1 reported row
SellerSecuritySale dateAmount soldGross proceeds
James E. DavisCommon06/01/202610,0001,941,400.00

Seller — prior-sale row 1, entry 1

Name
James E. Davis
Street
500 Plaza Drive
City
Secaucus
State / country code
NJ
Postal code
07094

Prior-sale reporting

Nothing to report for the preceding three months
N

Notice signature

Notice date
09/01/2026
Signed
/s/ Jennifer Ruchti, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for James E. Davis
Plan adoption dates
08/26/2025

Company context

Quest Diagnostics works across healthcare to create a healthier world, one life at a time. We help connect people, from clinicians to consumers, with laboratory insights that illuminate a path to better health. With a focus on delivering smarter, simpler testing, our insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics serves half the physicians and hospitals in the United States and one in three adult Americans each year, and our nearly 60,000 employees work together to deliver diagnostic insights that inspire actions to transform lives. www. QuestDiagnostics.com.

Current securities

Recent company filings

  1. SCHEDULE 13G - filed by STATE STREET CORP regarding QUEST DIAGNOSTICS INCNov 10, 2026
  2. 10-Q filingOct 23, 2026
  3. Other EventsOct 22, 2026
  4. Results of Operations and Financial ConditionOct 22, 2026
  5. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsOct 6, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.